PMLT18041 / AGCT1531 / Angela Girvin
Research Question:
Does monitoring patients with germ cell tumors help prevent tumors from recurring?
Basic Study Information
Purpose:
This phase III trial studies how well active surveillance, bleomycin, carboplatin,
etoposide, or cisplatin work in treating pediatric and adult patients with germ cell
tumors. Active surveillance may help doctors to monitor subjects with low risk germ
cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin,
carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of
tumor cells, either by killing the cells, by stopping them from dividing, or by stopping
them from spreading.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Angela Girvin
Study Contact Information
Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search